Advanced search
Start date
Betweenand

Manoela Tiago dos Santos

CV Lattes GoogleMyCitations


Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF)  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

graduation at Biotecnologia from Universidade Estadual Paulista Júlio de Mesquita Filho (2008) and master's at Pharmacy from Universidade de São Paulo (2011). Has experience in Biochemistry, focusing on Molecular Biology, acting on the following subjects: cultura de células, equivalente dérmico, mini-gene, terapia gênica and melanoma b16f10. (Source: Lattes Curriculum)

Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated October 17, 2020
Total / Available in English
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (2)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications2
Citations15
Cit./Article7.5
Data from Web of Science

SANDRI, SILVANA; WATANABE, LUIS R. M.; DE OLIVEIRA, ERICA APARECIDA; FAIAO-FLORES, FERNANDA; MIGLIORINI, SILENE; TIAGO, MANOELA; FELIPE-SILVA, ALOISIO; VAZQUEZ, VINICIUS DE LIMA; SOUZA, PAOLA DA COSTA; LOPES CONSOLARO, MARCIA EDILAINE; et al. Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance. PHARMACOLOGICAL RESEARCH, v. 159, . Web of Science Citations: 0. (17/04926-6, 17/26148-5, 12/05910-2, 11/19045-9, 16/16554-3, 13/05172-4, 15/10821-7)

TIAGO, MANOELA; DE OLIVEIRA, EDSON MENDES; BROHEM, CARLA ABDO; PENNACCHI, PAULA COMUNE; PAES, RAFAEL DUARTE; HAGA, RAQUEL BRANDAO; CAMPA, ANA; DE MORAES BARROS, SILVIA BERLANGA; SMALLEY, KEIRAN S.; MARIA-ENGLER, SILVYA STUCHI. Fibroblasts Protect Melanoma Cells from the Cytotoxic Effects of Doxorubicin. TISSUE ENGINEERING PART A, v. 20, n. 17-18, p. 2412-2421, . Web of Science Citations: 15. (11/19045-9, 10/15919-1)

Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: